Table 4.

Pharmacokinetics properties of predicted compounds and five known drugs. The pharmacokinetics properties comprised cytochrome inhibition, the blood brain barrier permeant (BBB), P-glycoprotein (P-gp) substrates, and gastrointestinal (GI) absorption.

Compound ZINC ID	GI Absorption	BBB Permeant	P-gp Substrate	CYP1A2 Inhibitor	CYP2C19 Inhibitor	CYP2C9 Inhibitor	CYP2D6 Inhibitor	CYP3A4 Inhibitor
ZINC95486006	Low	No	Yes	No	No	No	No	No
ZINC95486007	Low	No	Yes	No	No	No	No	No
ZINC38143792	High	No	Yes	No	No	No	No	No
ZINC95485880	High	Yes	Yes	No	No	No	No	No
ZINC95486305	High	No	Yes	No	No	No	No	Yes
ZINC95486303	Low	No	Yes	No	No	No	No	Yes
ZINC95485905	Low	No	No	No	No	Yes	No	No
ZINC95486183	Low	No	Yes	No	No	No	No	No
ZINC95486184	Low	No	Yes	No	No	No	No	No
ZINC95486142	Low	No	No	No	No	No	No	No
ZINC86037206	High	No	No	No	No	Yes	No	Yes
ZINC31761332	Low	No	No	No	No	Yes	No	Yes
ZINC95486231	High	No	Yes	No	No	No	No	No
ZINC03197457	Low	No	No	No	No	No	No	No
ZINC95485943	High	No	Yes	No	No	No	No	No
ZINC95486001	High	No	Yes	No	No	Yes	No	No
ZINC40431237	High	No	No	No	No	Yes	No	Yes
ZINC95486182	Low	No	No	No	No	No	No	No
ZINC03941105	High	No	No	No	No	Yes	No	No
ZINC95485882	Low	No	No	No	No	No	No	No
RIFAMPICIN	Low	No	Yes	No	No	No	No	No
STREPTOMYCIN	Low	No	Yes	No	No	No	No	No
CLARITHROMYCIN	Low	No	Yes	No	No	No	No	No
MOXIFLOXACIN	High	No	Yes	No	No	No	Yes	No
AMIKACIN	Low	No	Yes	No	No	No	No	No